KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,269,600 | -66.2% | 120,000 | +4.3% | 0.30% | -38.9% |
| Q4 2020 | $3,756,000 | -19.2% | 115,000 | -51.3% | 0.50% | -58.8% |
| Q2 2019 | $4,646,000 | +45.9% | 235,956 | +34.8% | 1.20% | +98.5% |
| Q2 2018 | $3,185,000 | +349.2% | 175,000 | 0.0% | 0.61% | -53.2% |
| Q1 2016 | $709,000 | +29.4% | 175,000 | +168.3% | 1.30% | +18.7% |
| Q4 2015 | $548,000 | – | 65,222 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |